These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 25247761)

  • 1. [Cost of Illness of HIV Patients under Anteretroviral Therapy in Germany - Results of the 48-Week Interim Analysis of the Prospective Multicentre Observational Study 'CORSAR'].
    Kuhlmann A; Mittendorf T; Hower M; Heiken H; Gerschmann S; Klauke S; Lutz T; Bogner J; Degen O; van Lunzen J; Bachmann C; Stellbrink HJ; Schmidt W; Leistner I; Mahlich J; Ranneberg B; Stoll M
    Gesundheitswesen; 2015 Jun; 77(6):e133-42. PubMed ID: 25247761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health economic burden of patients with restless legs syndrome in a German ambulatory setting.
    Dodel R; Happe S; Peglau I; Mayer G; Wasem J; Reese JP; Giani G; Geraedts M; Trenkwalder C; Oertel WH; Stiasny-Kolster K
    Pharmacoeconomics; 2010; 28(5):381-93. PubMed ID: 20297866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Social/economic costs and health-related quality of life in patients with histiocytosis in Europe.
    Iskrov G; Astigarraga I; Stefanov R; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Schieppati A; Taruscio D; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():67-78. PubMed ID: 27042831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and financial burdens of secondary level care in a public sector antiretroviral roll-out setting (G. F. Jooste Hospital).
    Kevany S; Meintjes G; Rebe K; Maartens G; Cleary S
    S Afr Med J; 2009 May; 99(5):320-5. PubMed ID: 19588792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe.
    López-Bastida J; Linertová R; Oliva-Moreno J; Posada-de-la-Paz M; Serrano-Aguilar P; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Baji P; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():99-108. PubMed ID: 27038627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social/economic costs and health-related quality of life in patients with scleroderma in Europe.
    López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Péntek M; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():109-17. PubMed ID: 27038626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lifetime cost of current human immunodeficiency virus care in the United States.
    Schackman BR; Gebo KA; Walensky RP; Losina E; Muccio T; Sax PE; Weinstein MC; Seage GR; Moore RD; Freedberg KA
    Med Care; 2006 Nov; 44(11):990-7. PubMed ID: 17063130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atrial fibrillation in Germany: A prospective cost of illness study].
    Spyra A; Daniel D; Thate-Waschke IM; Berghaus S; Willich S; Zeymer U; Rychlik R
    Dtsch Med Wochenschr; 2015 Jul; 140(14):e142-8. PubMed ID: 26182263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost evaluation of a model for integrated care of seriously mentally ill patients].
    Fischer F; Hoffmann K; Mönter N; Walle M; Beneke R; Negenborn S; Weinmann S; Willich SN; Berghöfer A
    Gesundheitswesen; 2014 Feb; 76(2):86-95. PubMed ID: 23737155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic costs and health-related quality of life outcomes of hospitalised patients with high HIV prevalence: A prospective hospital cohort study in Malawi.
    Maheswaran H; Petrou S; Cohen D; MacPherson P; Kumwenda F; Lalloo DG; Corbett EL; Clarke A
    PLoS One; 2018; 13(3):e0192991. PubMed ID: 29543818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of contemporary HIV/AIDS health care costs in Germany: Driving factors and distribution across antiretroviral therapy lines.
    Treskova M; Kuhlmann A; Bogner J; Hower M; Heiken H; Stellbrink HJ; Mahlich J; Schulenburg JM; Stoll M
    Medicine (Baltimore); 2016 Jun; 95(26):e3961. PubMed ID: 27367993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct costs for the treatment of HIV-infection in a German cohort after the introduction of HAART.
    Stoll M; Claes C; Schulte E; Graf von der Schulenburg JM; Schmidt RE
    Eur J Med Res; 2002 Nov; 7(11):463-71. PubMed ID: 12568973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ART treatment costs and retention in care in Kenya: a cohort study in three rural outpatient clinics.
    Larson BA; Bii M; Henly-Thomas S; McCoy K; Sawe F; Shaffer D; Rosen S
    J Int AIDS Soc; 2013 Jan; 16(1):18026. PubMed ID: 23305696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost of nucleoside analogue reverse transcriptase inhibitor-related toxicity in HIV-1-infected patients].
    Llibre-Codina JM; Casado-Gómez MA; Sánchez-de la Rosa R; Pérez-Elías MJ; Santos-González J; Miralles-Alvarez C; Martínez-Chamorro E; Domingo-Pedrol P; Alvarez-García ML; Moreno-Guillén S
    Enferm Infecc Microbiol Clin; 2007 Feb; 25(2):98-107. PubMed ID: 17288907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Brodszky V; von der Schulenburg JM; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1(Suppl 1):31-42. PubMed ID: 27107597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources.
    Ruof J; Hülsemann JL; Mittendorf T; Handelmann S; von der Schulenburg JM; Zeidler H; Merkesdal S
    Ann Rheum Dis; 2003 Jun; 62(6):544-9. PubMed ID: 12759292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social/economic costs and quality of life in patients with haemophilia in Europe.
    Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Gulácsi L; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():53-65. PubMed ID: 27048374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial burden of health care for HIV/AIDS patients in Vietnam.
    Tran BX; Duong AT; Nguyen LT; Hwang J; Nguyen BT; Nguyen QT; Nong VM; Vu PX; Ohinmaa A
    Trop Med Int Health; 2013 Feb; 18(2):212-8. PubMed ID: 23210600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The societal burden of HIV/AIDS in Northern Italy: an analysis of costs and quality of life.
    Hubben GA; Bishai D; Pechlivanoglou P; Cattelan AM; Grisetti R; Facchin C; Compostella FA; Bos JM; Postma MJ; Tramarin A
    AIDS Care; 2008 Apr; 20(4):449-55. PubMed ID: 18449822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On the economic burden of MRSA in Germany].
    Claus F; Sachse A; Ried W
    Gesundheitswesen; 2014 Dec; 76(12):800-6. PubMed ID: 25372655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.